Altimmune's total assets for Q1 2025 were $157.26M, an increase of 12.89% from the previous quarter. ALT total liabilities were $15.10M for the fiscal quarter, a -4.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.